Cargando…
Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
BACKGROUND: Diabetic macular oedema is the leading causes of blindness. Laser photocoagulation reduces the risk of visual loss. However recurrences are common and despite laser treatment, patients with diabetic macular oedema experienced progressive loss of vision. Stabilization of the blood retinal...
Autores principales: | Norlaili, Mustapha, Bakiah, Shaharuddin, Zunaina, Embong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231950/ https://www.ncbi.nlm.nih.gov/pubmed/22111945 http://dx.doi.org/10.1186/1471-2415-11-36 |
Ejemplares similares
-
Comparison of Photocoagulation With Combined Intravitreal Triamcinolone for Diabetic Macular Edema
por: Lee, Ho Young, et al.
Publicado: (2009) -
Comparison of Natural Course, Intravitreal Triamcinolone and Macular laser photocoagulation for Treatment of Mild Diabetic Macular Edema
por: Kwon, Soon Il, et al.
Publicado: (2013) -
Vitrectomy Combined with Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Nontractional Diabetic Macular Edema
por: Kim, Jae Hui, et al.
Publicado: (2013) -
Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
por: Choi, Kyung Seek, et al.
Publicado: (2007) -
Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013)